Rare Mutations in N-methyl-D-aspartate Glutamate Receptors in Autism Spectrum Disorders and Schizophrenia

DSpace/Manakin Repository

Rare Mutations in N-methyl-D-aspartate Glutamate Receptors in Autism Spectrum Disorders and Schizophrenia

Citable link to this page

 

 
Title: Rare Mutations in N-methyl-D-aspartate Glutamate Receptors in Autism Spectrum Disorders and Schizophrenia
Author: Tarabeux, J; Kebir, O; Hamdan, F F; Piton, A; Henrion, É; Millet, B; Fathalli, F; Joober, R; Rapoport, J L; Fombonne, É; Mottron, L; Forget-Dubois, N; Boivin, M; Michaud, J L; Drapeau, P; Lafrenière, R G; Rouleau, G A; Krebs, M-O; Gauthier, J.; DeLisi, Lynn E; Xiong, L.; Spiegelman, D.

Note: Order does not necessarily reflect citation order of authors.

Citation: Tarabeux, J., O. Kebir, J. Gauthier, F. F. Hamdan, L. Xiong, A. Piton, D. Spiegelman, et al. 2011. Rare mutations in n-methyl-d-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Translational Psychiatry 1(11): e55.
Full Text & Related Files:
Abstract: Pharmacological, genetic and expression studies implicate N-methyl-D-aspartate (NMDA) receptor hypofunction in schizophrenia (SCZ). Similarly, several lines of evidence suggest that autism spectrum disorders (ASD) could be due to an imbalance between excitatory and inhibitory neurotransmission. As part of a project aimed at exploring rare and/or de novo mutations in neurodevelopmental disorders, we have sequenced the seven genes encoding for NMDA receptor subunits (NMDARs) in a large cohort of individuals affected with SCZ or ASD (n=429 and 428, respectively), parents of these subjects and controls (n=568). Here, we identified two de novo mutations in patients with sporadic SCZ in GRIN2A and one de novo mutation in GRIN2B in a patient with ASD. Truncating mutations in GRIN2C, GRIN3A and GRIN3B were identified in both subjects and controls, but no truncating mutations were found in the GRIN1, GRIN2A, GRIN2B and GRIN2D genes, both in patients and controls, suggesting that these subunits are critical for neurodevelopment. The present results support the hypothesis that rare de novo mutations in GRIN2A or GRIN2B can be associated with cases of sporadic SCZ or ASD, just as it has recently been described for the related neurodevelopmental disease intellectual disability. The influence of genetic variants appears different, depending on NMDAR subunits. Functional compensation could occur to counteract the loss of one allele in GRIN2C and GRIN3 family genes, whereas GRIN1, GRIN2A, GRIN2B and GRIN2D appear instrumental to normal brain development and function.
Published Version: doi:10.1038/tp.2011.52
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309470/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10340523
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters